PGs can be produced through the successive conversion of arachidonic acid by major isoenzymes, COX
INTRODUCTION
Microglia, the immune regulatory and infl ammatory cells play a role in host defense and tissue repair in the central nervous system (CNS) (Perry and Gordon, 1988) . They can be activated in response to a variety of neurodegenerative and neuro-infl ammatory conditions, resulting in the amplication of infl ammation and the mediation of cellular degeneration (Gonzalez-Scarano and Baltuch, 1999) . The activation of microglia leads to the induction of infl ammatory enzymes such as inducible nitric oxide synthase (iNOS) and cyclooxygenase (COX-2), as well as the release of proinfl ammatory cytokines including TNF-α, IL-1β, IL-6 (Allen and Tresini, 2000; Klein and Ackerman, 2003) . The infl ammatory mediators produced by activated microglia are responsible for the neurodegenerative disorders, including Alzheimer's disease and Parkinson's disease (McGeer and McGeer, 1995; Block et al., 2007) .
Prostaglandins (PGs) are lipid mediators that regulate several physiologic and pathophysiologic processes in both homeostatic and infl ammatory conditions (Harris et al., 2002) .
The activation of microglia induces the overproduction of infl ammatory mediators that are responsible for the neurodegenerative disorders including Alzheimer's disease and Parkinson's disease. The large amounts of prostaglandin E 2 (PGE 2 ) produced by inducible cyclooxygenase (COX-2) is one of the main infl ammatory mediators that can contribute to neurodegeneration. The inhibition of COX-2 thus may provide therapeutic strategy for the treatment of neurodegenerative diseases. From the activityguided purifi cation of EtOAc soluble fraction of Siegesbeckia glabrescens, four compounds were isolated as inhibitors of PGE 2 production in LPS-activated microglia. Their structures were determined as 3, 4'-dimethylquercetin (1), 3, 7-dimethylquercetin (2), 3-methylquercetin (3) and 3, 7, 4'-trimethylquercetin (4) by the mass and NMR spectral data analysis. The compounds 1-4 showed dose-dependent inhibition of PGE 2 production in LPS-activated microglia with their IC 50 values of 7.1, 4.9, 4.4, 12.4 μM respectively. They reduced the expression of protein and mRNA of COX-2 through the inhibition of I-κBα degradation and NF-κB activity that were correlated with the inactivation of p38 and ERK. Therefore the active compounds from Siegesbeckia glabrescens may have therapeutic effects on neuro-infl ammatory diseases through the inhibition of overproduction of PGE 2 and suppression of COX-2 overexpression.
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We have screened anti-infl ammatory activity of plant extracts which has been used as folk medicine. We have reported sesquiterpenes (Yoon et al., 2008) , lignans (Ryu et al., 2002) and fl avonoids (Lee et al., 2005) that can inhibit the expression of iNOS and COX-2 in activated microglia. Here, we report the identifi cation of four quercetin derivatives from Siegesbeckia glabrescens and their inhibitory activities of PGE 2 production, COX-2 expression and NF-κB activation.
MATERIALS AND METHODS

Plant materials
The whole plant of Siegesbeckia glabrescens was collected from Wan-Do, Jeolla-Namdo, Korea in November 2005. The obtained material (2.7 kg) was air-dried and extracted three times with 2 l of methanol at RT for 24 h. The extracted solution was fi ltered and evaporated in vacuo, the residue (190 g) was successively partitioned with n-hexane, EtOAc, CHCl 3 and BuOH. The activity-guided chromatography was followed for the purifi cation of bioactive compounds as reported previously . Four fl avonoids were isolated from the EtOAc soluble fraction by repeated column chromatography on silica gel using gradient elution with n-hexane-acetone, n-hexane-EtOAc and CHCl 3 -MeOH. For further purifi cation, RP-C18 column (LiChroprep RP-C18, 40-63 μm, Merck) was used with a gradient elution of MeOH/water (50%→100%). The purity of compounds was confi rmed by reverse phase HPLC analysis (Inertsil ODS-2, 4.6×100 mm; 80% MeOH, 1.0 ml/min; UV 254 nm). The structure of compounds was identifi ed by the analysis of IR, Mass and NMR spectroscopic data analysis.
Cell culture
Murine microglial cell line (BV-2) was kindly provided by Prof. Hee-Sun Kim at Ewha Womans University, Korea. Cells were cultured in DMEM containing 10% fetal bovine serum, 2 mM glutamine, 1 mM pyruvate, penicillin (100 U/ml) and streptomycin (10 μg/ml). BV-2 cells were seeded at 5×10 5 cells/ml in 48 well plates and were activated by incubation in medium containing LPS (0.1 μg/ml, Escherichia coli, 0127:B8, Sigma, St. Louis, MO) and various concentrations of test compounds dissolved in DMSO (0.1 % fi nal concentration in media). The supernatant was collected as a source of secreted PGE 2 .
Measurement of prostaglandin E 2
PGE 2 enzyme immunometric assay (EIA) was performed according to Pradelles (Pradelles et al., 1985) with the minor modifi cation (Cayman Chemical, Ann Arbor, MI). In brief, 50 μl of supernatant from the culture medium and 50 μl PGE 2 EIA tracer were put into the PGE 2 EIA 96-well plate and the plate were incubated for 18 h. Wells were washed with 10 mM phosphate buffer (pH 7.4) containing 0.05% Tween 20, followed by the addition of 200 μl of Ellman's reagent and incubation at RT. Following the developing step, absorbance in each well at 405 nm was read using a microplate spectrometer. A standard curve was developed simultaneously with standard ranging from 0.06 to 6 pg/μl PGE 2 .
Western blot analysis
The cells were rinsed with phosphate buffered saline and lysed by boiling with lysis buffer (1% SDS, 1.0 mM sod. vanadate, 10 mM Tris, pH 7.4) for 5 min. Twenty μg protein of cell lysates was applied on SDS-polyacrylamide gels and transferred to PVDF membrane by the standard method. The membrane was probed with antibodies against COX-2 (Cayman Chemical Company, Ann Arbor, MI), β-actin (Sigma Chemical Co., St. Louis, MO), I-κBα and p65 (Santa Cruz Biotechnologies Inc. Santa Cruz, CA). Antibodies against ERK1/2, phospho-ERK1/2, p38, phospho-p38, JNK, and phospho-JNK were from Cell Signaling Technology (Beverly, MA). The blot was visualized using an enhanced chemiluminescence (ECL) detection kit (Amersham bioscience, Piscataway, NJ) according to the manufacturer's instruction.
Reverse transcription and polymerase chain reaction (RT-PCR)
BV-2 cells were pre-treated with and without plant samples for 30 min prior to LPS (0.1 μg/ml) for 4 h. The whole RNA was isolated with TRIzol Ⓡ reagent (Invitrogen, Carlsbad, CA). Each RNA extract (2 μg) was reverse-transcribed into cDNA using superscript II reverse transcriptase (Invitrogen, Carlsbad, CA). PCR was performed in 25 μl of a solution containing Go Taq TM DNA polymerase (Promega, Madison, WI), COX-2 primer, α-actin primer, and RT products. The sense and antisense primers for COX-2 were 5'-CCAGATGCTATCTTT-GGGGAGAC-3' and 5'-CTTGCATTGATGGTGGCTG-3', respectively. The sense and antisense primers for α-actin were 5'-TGTGATGGTGGGAATGGGTCAG-3' and 5'-TTTGATGT-CACGCACGATTTCC-3', respectively. After preincubation for 5 min at 94 o C, 30 cycles of amplifi cation (94 o C for 30 s, 30 o C for 30 s and 72 o C for 1 min) were performed for COX-2. After preincubation for 3 min at 94 o C, 26 cycles of amplifi cation (94 o C for 1 min, 64 o C for 1 min and 72 o C for 1 min) were performed for α-actin. The level of α-actin was used for an internal control. Each PCR reaction was analyzed by 2% agarose gel electrophoresis in Tris acetate-EDTA buffer and stained with ethidium bromide.
NF-κB luciferase assay
BV-2 cells were seeded at 1×10 5 cells/ml in 48 well plates. After incubating at 37 o C for 24 h, the cells were transfected with 0.5 μg of NF-κB luciferase reporter plasmid and 0.3 μg of β-galactosidase plasmid in DMEM medium without FBS using SuperFect reagent according to the manufacturer's protocol (Qiagen, Valencia, CA). The cells were incubated for 3 h, and then fresh 10% FBS DMEM medium was added. After 18 h, the cells were preincubated with or without samples before being activated with LPS for 6 h. The luciferase activity was determined using the luciferase assay system (Promega, Madison, WI) with a microplate luminometer (Wallac Victor3 TM 1420 Multi Lable Counter, Perkin Elmer). The β-galactosidase activity was determined as described previously (Ye et al., 1994) . The results are expressed as relative NF-κB activity compared with controls after normalizing for β-galactosidase activity.
Electrophoretic mobility shift assay
BV-2 cells were seeded at 1.0×10 6 cells/ml in 60 mm dish for 24 h and were treated with and without samples and LPS (0.1 μg/ml) for 15 min. The cells were rinsed with phosphate buffered saline and lysed with 10 mM HEPES-KOH, 10 mM www.biomolther.org KCl, 1.5 mM MgCl 2 , 0.5 mM DTT, 0.5 mM PMSF, 0.1 mM EDTA, 0.2 mM NaF and 0.2 mM sod. orthovanadate (pH 7.9) for 15 min. Nuclear protein was extracted in 50 mM HEPES-KOH, 50 mM KCl, 1.5 mM MgCl 2 , 300 mM NaCl, 0.5 mM DTT, 0.5 mM PMSF, 0.1 mM EDTA, 0.2 mM NaF, 0.2 mM sod. orthovanadate and 25% glycerol (pH 7.9) on ice for 30 min. After cells were centrifuged for 20 min at 14,000×g, supernatants with nuclear proteins were transferred into pre-cooled tube and protein concentrations were determined. Equal amount (15 μg) of nuclear protein from the cells were reacted with 32 P-labeled oligonucleotide specifi c to NF-κB in a binding buffer (10 mM HEPES-KOH, 50 mM KCl, 2.5 mM MgCl 2 , 10 mM DTT, 1 μg/ml poly (dI-dC), and 5% glycerol, pH 7.4) for 10 min on ice. The complexes between oligonucleotide and nuclear protein were resolved on non-denaturing 6% polyacrylamide gel by electrophoresis. The gels were dried and exposed to X-ray fi lm.
Statistics
The results were expressed as mean ± S.D. of three experiments, and statistical analysis was performed by the Student's t-test, and a p-value of <0.05 was considered to indicate a signifi cant difference.
RESULTS AND DISCUSSION
Microglia are immune cells found in CNS that can be activated by the exposure of lipopolysaccharide (LPS), interferon-γ or β-amyloid (Zielasek and Hartung, 1996; Lehnardt et al., 2003) . Activated microglia release various kinds of neurotoxic factors, including PGE 2 , nitric oxide (NO) and pro-infl ammatory cytokines that can result in brain injury and neurodegenerative diseases including Alzheimer's diseases, Parkinson's disesase and traumatic multiple sclerosis. Therefore, the regulation of microglial activation might lead to the useful strategies for the treatment of neurodegenerative disorders.
As a part of our on-going screening program to evaluate the anti-infl ammatory potentials of plant-derived compounds (Ryu et al., 2002; Lee et al., 2005; Yoon et al., 2008) , we investigated the inhibitors of PGE 2 synthesis in LPS-activated microglia. Siegesbeckia glabrescens (Compositae), well known as 'Hi-Chum' has been used as traditional medicine for the treatment of rheumatoid arthritis, asthma, paralysis and allergic disorders. Recently, it has been reported that the extracts of S. glabrescens exhibit antioxidant, antiallergic, antihypertension, antitumor, and anti-infl ammatory activities Jun et al., 2006; Kim et al., 2008) .
In order to screen the biological activity of plant-derived principles, we used the LPS-activated microglial system. The stimulation of microglia is a useful model for the activity screening of neuroprotective agents by monitoring infl ammatory mediators. The activation of microglia has been considered to be related with various pathological process during neuropathological changes of central nervous system. The treatment of LPS (0.1 μg/ml, 20 h) into microglial cell, BV-2 cells, increased the production of PGE 2 up to 5 pg/well as a main infl ammatory mediator produced by COX-2. From the activity-guided purifi cation process using EtOAc soluble fraction of Siegesbeckia glabrescens, we isolated four inhibitors (1-4) of PGE 2 production in activated BV-2 cells (Fig. 1) . Their structures were elucidated as 3,4'-dimethylquercetin (1), 3,7-dimethylquercetin (2), 3-methylquercetin (3) and 3,7,4'-trimethylquercetin (4) by spectroscopic analysis and confi rmed by the comparison of the reported data (Ramachandran Nair et al., 1978; Barberá et al., 1986; Wang et al., 1989) .
To evaluate the anti-infl ammatory potential of compounds, we determined the PGE 2 level in LPS-activated microglia. Cells were allowed to adhere for 2 h, in the presence of aspirin (500 μM) to inactivate endogenous COX-1. And then, cells were washed three times with fresh media and incubated with LPS (0.1 μg/ml) and test compounds for 20 h. The amounts of PGE 2 released into culture media were analyzed by PGE 2 enzyme immunoassay kit. Compounds 1-4 inhibited PGE 2 production in LPS-activated BV-2 microglia in a dose dependent manner. The IC 50 values, the concentrations of compounds 1-4 responsible for the 50% inhibition of PGE 2 production, were 7.1, 4.9, 4.4, 12.4 μM, respectively (Fig. 1) . The quercetin derivatives 2 and 3 were somewhat stronger inhibitors than 1 and 4. The methylation of 4' position of ring B reduced the inhibitory activity of PGE 2 production. The activity of quercetin was the weakest among the tested derivatives with IC 50 value of 32 μM that was the relevant value of reported data (Chen et al., 2001) . Cell viability was above 85% at the concentrations of PGE 2 assay when assessed by MTT method. The inhibition of PGE 2 production might come from either the inhibition of COX-2 enzyme activity or the suppression of COX-2 induction. In order to reveal the mechanism for the inhibition of PGE 2 production, we analyzed the effects of compounds on the expression level of protein and mRNA of COX-2 in LPSactivated microglia. The cell lysate of vehicle treated cells did not show detectable COX-2 protein. The treatment of 1-4 (20 μM) showed the signifi cant decrease of the COX-2 protein expression by LPS-activated microglia (Fig. 2) . The results of reverse transcription-polymerase chain reaction (RT-PCR) analysis also showed that compounds 1-3 (20 μM) inhibited the expression of COX-2 mRNA in LPS-activated microglia (Fig.  3) . The amounts of protein and mRNA expression were quantitated from the volume intensity of the bands corresponding to COX-2 and actin.
To elucidate the further mechanism of compounds for COX-2 inhibition in microglia, we determined effects of compounds on the NF-κB activity and level of I-κBα in LPS-activated microglia. NF-κB is an important transcription factor for proinfl ammatory mediators including iNOS and COX-2 induction (Kim et al., 1997). The NF-κB can be activated by the degradation of inhibitory-κB (I-κB) through its phosphorylation . I-κBα was fully degraded by 30 min exposure of LPS (0.1 μg/ml) and followed by the recovery in microglia (data not shown) (Lee et al., 2005) . As shown in Fig. 4 , the degradation of I-κBα was suppressed by the 30 min treatment of 1-4 (20 μM) during the LPS activation of microglia. The NF-κB activity was measured by the luciferase reporter gene assay and electrophoretic mobility shift assay (EMSA). As shown in Fig.  5 , compounds 1-3 (20 μM) suppressed the NF-κB reporter activity. Compounds 1-3 also suppressed LPS-induced NF-κB binding activity (Fig. 6 ) in EMSA analysis.
In previous studies, it has been demonstrated that the MAP kinase (MAPK) pathways are involved in LPS-induced production of COX-2 and iNOS via control of NF-κB activation in microglial cells (Moon et al., 2007; Jung et al., 2009) . To investigate the molecular mechanisms involved in the inhibition of NF-κB activation, we examined the effect of compounds on LPS-stimulated phosphorylation of ERK1/2, p38, and JNK in microglial cells. Cells were pretreated with compounds for 30 min and then stimulated with LPS (0.1 μg/ml) for 30 min. The phosphorylation of ERK1/2, p38 and JNK was increased by LPS stimulation. Compounds 1-4 reduced LPS-induced phosphorylation of p38 and ERK1/2, whereas phosphorylation of JNK was not affected (Fig. 7) . Non-phosphorylated ERK1/2, p38 and JNK were not changed by the treatment of LPS and test compounds. These results indicate that the suppressed phosphorylation of p38 and ERK1/2 may contribute to the inhibitory effect of compounds on LPS-induced NF-κB activation and pro-infl ammatory responses in microglial cells.
These activities could be extrapolated to the inhibition of other infl ammatory mediators such as IL-1β, IL-6 and TNF-α, whose levels are regulated by NF-κB pathway. The further activity mechanism and the permeability of blood-brain barrier of the active compounds should be investigated for the successful drug development for CNS. Microglia are resident macrophage-like cells that play a role in host defense and tissue repair in the CNS (Perry and Gordon, 1988) . However, activated microglia play a pivotal role in the amplication of infl ammation and the mediation of cellular degeneration (Gonzalez-Scarano and Baltuch, 1999) . PGE 2 released from activated microglia participates in the process of neuronal cell death through DNA damage and mitochondrial disruption. COX-2 is expressed in activated microglia which appear to be an important source of PGs during infl ammation conditions (Bauer et al., 1997) . Therefore, inhibition of these mediators may have benefi cial effects in the treatment of neuronal infl ammatory reaction and diseases.
In summary, four fl avonoids, 3,4'-dimethylquercetin (1), 3,7-dimethylquercetin (2), 3-methylquercetin (3) and 3,7,4'-trimethylquercetin (4) were isolated from Siegesbeckia glabrescens as inhibitors of PGE 2 production in LPS-activated microglia. They exerted their activity through the inhibition of NF-κB activation and subsequent suppression of protein and mRNA expression of COX-2. These results imply that Siegesbeckia glabrescens may be benefi cial in the treatment of neuro-infl ammatory diseases through the inhibition of PGs.
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